Skip to content

Train with us

Explore

StudentsStudent union partnership: your class fund
Sign upLog in

Published on

Qu'est-ce que le nerf d'Arnold ?

Le nerf d'Arnold, ou nerf grand occipital, naît du deuxième nerf du cou (C2), traverse les muscles de la nuque et remonte à l'arrière de la tête. Il donne la sensibilité du cuir chevelu, de la base du crâne jusqu'au sommet de la tête. Lorsqu'il est irrité sur son trajet, la douleur suit ce chemin : elle part de la base du crâne et remonte vers le sommet, le plus souvent d'un seul côté, parfois des deux.

Physiotherapy · Headache · Neuropathic pain

Occipital neuralgia (greater occipital nerve neuralgia) 2026 update

In brief

Occipital neuralgia, historically known in France as Arnold's neuralgia, is a secondary headache (ICHD-3 13.4) characterised by paroxysmal stabbing pain in the territory of the greater occipital nerve, often unilateral, with dysaesthesia or allodynia and tenderness on palpation of the nerve. The diagnosis is clinical and confirmed by temporary relief after an anaesthetic block of the nerve concerned, considered the gold standard. First-line management is conservative: pain education, ergonomic correction, exercise for the deep cervical flexors and cervical extensors, and manual therapy. It affects 73 % women, of mean age 56.

Clinical synthesis based on the ICHD-3 criteria (13.4), the Melchior 2025 epidemiological meta-analysis, the Deuel 2024 review of conservative management and the most recent meta-analyses (Hong 2024, Demont 2023, Núñez-Cabaleiro 2022, Liu 2025).

ICHD-3 13.4 diagnosis GON block Upper cervical physiotherapy Evidence-based
73%
of patients are women
Melchior 2025 · SR/MA 15 studies, n=579
81%
of presentations are unilateral
Melchior 2025 · Cephalalgia
56years
mean age of patients
Melchior 2025 · median age 53

Clinical summary

  • The condition known as occipital neuralgia is an ICHD-3 13.4 secondary headache characterised by paroxysmal stabbing pain in the territory of the greater occipital nerve (GON), the lesser occipital nerve (LON) or the third occipital nerve (TON), often unilateral (81 %, Melchior 2025).
  • Epidemiology: it affects women preferentially (73 %), mean age 56; incidence historically reported at 3.2 per 100 000 person-years (Koopman 2009, a Dutch cohort of 360 000 subjects), with a revision expected from the 2025 data.
  • Aetiology: mechanical compression or irritation of the GON along its course (as it passes through semispinalis and trapezius, Janis 2010), post-traumatic (whiplash), degenerative (C2-C3), vascular (occipital artery), tumour (schwannoma), inflammatory or post-herpetic.
  • Pathophysiology: focal neuropathy plus peripheral and central sensitisation (Treede 2008, Finnerup 2016); trigeminocervical convergence explains the fronto-orbital radiation.
  • Course: chronic and recurrent, alternating attacks and remissions; the natural history is insufficiently documented by longitudinal cohorts.
  • Clinical diagnosis = ICHD-3 13.4: paroxysmal pain in the territory + dysaesthesia/allodynia + tenderness on palpation + temporary relief from an anaesthetic block of the nerve concerned.
  • The key examination: palpation reproducing the pain about 2-3 cm lateral and inferior to the external occipital protuberance; Tinel's sign may be present. No validated specific score exists to date.
  • An anaesthetic GON block is the diagnostic gold standard according to ICHD-3; its therapeutic value is documented (Cohen 2015 RCT, Shauly 2019 SR/MA).
  • Differential diagnosis is essential: cervicogenic headache (ICHD-3 11.2.1), migraine (1), tension-type headache (2), trigeminal neuralgia (13.1), post-traumatic headache, TON involvement (Bogduk 2009).
  • Primary vs secondary classification: the secondary form (post-traumatic, compressive, tumour) calls for treatment of the cause as well.
  • Self-management is the cornerstone: pain education, ergonomic correction (forward head posture), sleep hygiene, stress management.
  • Therapeutic exercise: training the deep neck flexors (craniocervical flexion test, Jull 2008), endurance of the cervical extensors, scapular stabilisers (Demont 2023 PM&R).
  • Manual therapy: C0-C1-C2 mobilisations, soft-tissue techniques for the suboccipital muscles; efficacy documented for cervicogenic headache (Núñez-Cabaleiro 2022, Jull 2002).
  • A stepped treatment algorithm: physiotherapy/education → GON block ± steroid → repeated blocks → pulsed radiofrequency (Hong 2024) → decompression surgery (Liu 2025) as a last resort.
  • Return to activity is driven by functional criteria (pain < 3/10, full cervical range) rather than by a fixed delay.
  • Red flags (Finucane 2020): an unusual or thunderclap headache, fever, neurological deficit, a history of cancer, unexplained weight loss, immunosuppression.
  • Recommended PROMs: VAS / NRS, Neck Disability Index (NDI), HIT-6, MIDAS, PCS for catastrophising, TSK-11 for kinesiophobia.
  • Overall level of evidence: moderate (GRADE) for physiotherapy in cervicogenic headache, and low to moderate for the interventions specific to occipital neuralgia, given how few dedicated RCTs exist (Deuel 2024).

Contents

  1. What are the fundamentals to know about occipital neuralgia?
    1. How is this condition defined, who does it affect and what are the risk factors?
    2. What happens in the body, and how does occipital neuralgia evolve naturally?
  2. How do you assess and diagnose occipital neuralgia with certainty?
    1. Which questions should you ask to understand the patient and their history?
    2. Which clinical tests should you perform, and which other conditions should you rule out?
    3. Should patients with occipital neuralgia be classified, and what are the benefits?
  3. Which treatment strategies are the most effective for occipital neuralgia?
    1. Where do you start? What is the recommended hierarchy of interventions?
    2. What is the place of exercise, and is there a superior approach?
    3. Manual therapies, technologies: how effective are they really?
    4. Beyond the physical: how do you educate the patient and address psychological factors?
  4. How do you secure lasting recovery and prevent recurrence of occipital neuralgia?
    1. How do you make the patient an active participant in their recovery through self-management?
    2. When and how should a safe return to activity and to sport be planned?
  5. What do real clinical cases teach us about occipital neuralgia?
    1. Analysis of a “classic” case: from assessment to conservative resolution.
    2. The diagnostic challenge: when occipital neuralgia mimics another condition.
    3. A complex case: serious secondary causes.
  6. How do you apply these recommendations concretely in your practice?
    1. When and to which other health professionals should you refer?
    2. How do you measure outcomes and overcome barriers to implementation?

What are the fundamentals to know about occipital neuralgia?

In this chapter: the contemporary ICHD-3 13.4 definition, consolidated epidemiology (Melchior 2025 SR/MA, Koopman 2009 cohort), aetiological factors (compression, trauma, vascular, tumour), neuropathic pathophysiology (Treede 2008, Finnerup 2016) and the natural trajectory.
Greater occipital nerve neuralgia, known in France as “Arnold's neuralgia” after the German physician Friedrich Arnold (1803-1890), is a secondary headache codified in the third edition of the International Classification of Headache Disorders (ICHD-3) under the number 13.4: occipital neuralgia.¹ Recognising it precisely matters, because it determines the direction of treatment: as a focal neuropathic condition, it does not respond to the usual strategies for migraine or tension-type headache. 🎯

How is this condition defined, who does it affect and what are the risk factors?

ICHD-3 defines occipital neuralgia as unilateral or bilateral paroxysmal pain in the territory of the greater occipital nerve (GON), the lesser occipital nerve (LON) or the third occipital nerve (TON), with dysaesthesia and/or allodynia, with tenderness on palpation of the nerve concerned, and relieved by a local anaesthetic block.¹ The pain is typically described as an electric shock, a stab or a burn, lasting from a few seconds to a few minutes per attack, often followed by a residual dull ache.² 🎯 Consolidated epidemiology 2025. The systematic meta-analysis by Melchior et al. (Cephalalgia 2025, 15 pooled studies, n=579 patients) is now the most solid epidemiological reference.² It reports:
  • 73 % of the patients diagnosed are women (a proportion consistent across studies);
  • Mean age 56 years (median 53), with a peak incidence in the fifth and sixth decades;
  • Presentation unilateral in 81 % of cases;
  • A shooting or stabbing character in 59 %, severe in 54 %;
  • Marked heterogeneity in the incidence estimates from one study to the next, underlining the need for uniform diagnostic criteria.
The historically cited incidence (3.2 per 100 000 person-years) comes from the Dutch cohort of Koopman et al. (Pain 2009), covering 360 000 people followed for facial pain in primary care.³ That estimate is still cited in the literature, but should be read with caution: it includes cases diagnosed clinically without systematic confirmation by anaesthetic block. Clinical features of occipital neuralgia: Melchior 2025 meta-analysis Clinical features: Melchior 2025 (n=579) SR/MA of 15 studies, Cephalalgia 2025 · PMID 40017062 Women 73 % Unilateral presentation 81 % Shooting / stabbing character 59 % Severe intensity 54 % Relief from a GON block 89 % Sources: Melchior AG et al. Epidemiology and clinical features of occipital neuralgia: SR/MA. Cephalalgia 2025. PMID 40017062 Notable heterogeneity between studies; the ICHD-3 criteria were not applied systematically. 🧠 Aetiologies: one nerve, many causes. The condition results from irritation, compression or focal demyelination of the nerve along its course. The causes fall into two broad categories. Secondary causes (the most frequent):
  • Mechanical / compressive : compression by semispinalis capitis or trapezius at the point where the nerve pierces the aponeurosis (Janis 2010, the reference anatomical study of the compression points, PRS Part II)⁴; osteoarthritis of the C1-C2 or C2-C3 facet joints.
  • Traumatic : whiplash, direct craniocervical trauma, repeated microtrauma (occupational posture, previous posterior cervical surgery).
  • Vascular : a loop of the occipital artery in contact with the GON, aneurysms, malformations (see the case PMC5346380, Choi 2017)⁵; a C2 cavernoma (PMC5898127).⁶
  • Tumour : schwannoma of the GON or of the C2 root (Krishnan 2015, PMID 26752925)⁷; metastasis to the occipital condyle (PMC9985513).⁸
  • Inflammatory / infectious : occipital shingles with post-herpetic neuralgia; inflammatory arthritis of the upper cervical joints.
  • Malformation : associated Chiari I malformation (PMC5788399).⁹
The primary (idiopathic) form : accepted after clinical, and where appropriate imaging, exclusion of a secondary cause. It accounts for a substantial share of cases in primary care.

🚩 Specific red flags to consider in occipital headache

  • A thunderclap headache or one of sudden onset → subarachnoid haemorrhage, vertebral dissection
  • Fever + neck stiffness → meningitis, osteomyelitis
  • A focal neurological deficit (weakness, ataxia, visual disturbance) → posterior fossa stroke, Chiari malformation, tumour
  • A known history of cancer or unexplained weight loss → metastasis, neoplastic infiltration
  • Immunosuppression or a context of recent shingles → post-herpetic neuralgia, opportunistic infection
  • Progressive worsening over a few weeks with resistance to well-conducted treatment → a compressive mass (schwannoma, metastasis)
  • Presentation in a child or a young adult → secondary causes are more frequent (Ehresman 2023, paediatric cohort)¹⁰

⚠️ Any red flag → cervical and brain MRI before any invasive procedure, and prompt medical referral (neurologist, or the emergency department depending on the context).

What happens in the body, and how does occipital neuralgia evolve naturally?

🧠 Neuropathic pathophysiology. The greater occipital nerve, the dorsal branch of the C2 spinal nerve, runs upwards through layers of muscle (obliquus capitis inferior, semispinalis capitis) before becoming superficial as it pierces the trapezius aponeurosis about 2-3 cm lateral and inferior to the external occipital protuberance , the key anatomical landmark of the clinical examination.⁴ Cesmebasi 2015 (Clin Anat) lists the many potential sites of mechanical conflict: the muscular passage, the aponeurotic point, and vascular contact with the occipital artery.¹¹ Chronic irritation of the nerve produces focal demyelination, peripheral sensitisation (a lowered activation threshold in the nociceptors) and, beyond that, central sensitisation. Treede et al. (Neurology 2008) set out the operational definition of neuropathic pain with a possible/probable/definite grading, updated by Finnerup et al. (Pain 2016).¹²,¹³ This central sensitisation, mediated by hyperexcitability of the neurons of the trigeminocervical complex, explains:
  • Scalp allodynia (pain triggered by a normally non-painful stimulus, such as brushing the hair or contact with the pillow);
  • The radiation towards the frontal, orbital and even maxillary regions, through trigeminocervical convergence, described precisely by Bogduk & Govind (Lancet Neurology 2009) in their review of cervicogenic headache.¹⁴
🔄 Natural course. Occipital neuralgia is typically a chronic recurrent condition, alternating paroxysmal painful attacks with periods of relative remission. The Melchior 2025 meta-analysis stresses the lack of sufficient longitudinal data to characterise the natural history precisely, which is a gap in the literature to flag to patients.² Factors likely to worsen the course include:
  • Persistence of the mechanical factors (posture, occupational movements);
  • An unidentified secondary cause (a progressive structural compression);
  • Neuropathic or inflammatory comorbidity;
  • Psychosocial factors (kinesiophobia, catastrophising, sleep disturbance), major modulators of pain becoming chronic (Su 2022 on central sensitisation in migraine, applicable by analogy).¹⁵
“Occipital neuralgia is not a diagnosis of exclusion; it is a positive clinical diagnosis founded on precise ICHD-3 criteria and confirmed by the response to an anaesthetic block. The diagnostic fragmentation between migraine, cervicogenic headache and occipital neuralgia calls for a structured approach, not for hasty labelling.”

Key points

  • The ICHD-3 13.4 definition : paroxysmal pain in the territory of an occipital nerve + dysaesthesia/allodynia + tenderness on palpation + relief from an anaesthetic block.
  • The 2025 epidemiology (Melchior, SR/MA): 73 % women, mean age 56, 81 % unilateral, 59 % stabbing.
  • Aetiologies : compressive (muscular, degenerative), traumatic (whiplash), vascular, tumour (schwannoma), inflammatory (shingles) or idiopathic.
  • Pathophysiology : focal neuropathy plus peripheral and central sensitisation through the trigeminocervical complex.
  • Course : chronic and recurrent; the gap in longitudinal data should be flagged to the patient.
Bibliography
  1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. PMID 29368949. doi:10.1177/0333102417738202.
  2. Melchior AG, Al-Khazali S, Christensen RH, Al-Khazali HM, Ashina H. Epidemiology and clinical features of occipital neuralgia: A systematic review and meta-analysis. Cephalalgia. 2025;45(2):3331024251317595. PMID 40017062.
  3. Koopman JS, Dieleman JP, Huygen FJ, de Mos M, Martin CG, Sturkenboom MC. Incidence of facial pain in the general population. Pain. 2009;147(1-3):122-127. PMID 19783099.
  4. Janis JE, Hatef DA, Reece EM, McCluskey PD, Schaub TA, Guyuron B. The anatomy of the greater occipital nerve: Part II. Compression point topography. Plast Reconstr Surg. 2010;126(5):1563-1572. PMID 20639804.
  5. Choi JG, Kang YJ, Kim BC, Lee CG, Choi SK. Hemifacial Pain and Hemisensory Disturbance Referred from Occipital Neuralgia Caused by Pathological Vascular Contact of the Greater Occipital Nerve. Case Rep Neurol Med. 2017;2017:3827230. PMC 5346380.
  6. Occipital neuralgia from C2 cavernous malformation. Surg Neurol Int. 2018. PMC 5898127.
  7. Krishnan A, Kartikueyan R, Chowdhury SR, Das S. Schwannoma of the greater occipital nerve: An uncommon cause of occipital neuralgia. J Neurosci Rural Pract. 2015;6(4):634-636. PMID 26752925.
  8. Occipital condyle syndrome as the initial presentation of recurrence of metastatic breast cancer. Case report. 2023. PMC 9985513.
  9. Occipital Neuralgia in Chiari I Malformation. Acta Neurochir Suppl. 2018. PMC 5788399.
  10. Ehresman J, Polly DW, Hsu W, Witham TF, Lubelski D. Surgical management of pediatric occipital neuralgia: a single-center experience. J Neurosurg Pediatr. 2023;32(4):514-519. PMID 37548543.
  11. Cesmebasi A, Muhleman MA, Hulsberg P, Gielecki J, Matusz P, Tubbs RS, Loukas M. Occipital neuralgia: anatomic considerations. Clin Anat. 2015;28(1):101-108. PMID 25244129.
  12. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630-1635. PMID 18003941.
  13. Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157(8):1599-1606. PMID 27115670.
  14. Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence on clinical diagnosis, invasive tests, and treatment. Lancet Neurol. 2009;8(10):959-968. PMID 19747657.
  15. Su M, Yu S. Central Sensitization in Migraine: A Narrative Review. J Pain Res. 2022;15:2673-2682. PMC 9464439.
Physio Learning runs courses in this clinical area, eligible for DPC and FIFPL funding.See the course

How do you assess and diagnose occipital neuralgia with certainty?

In this chapter: history-taking targeted on the ICHD-3 criteria, clinical examination (GON palpation, Tinel, cervical mobility), the anaesthetic block as gold standard, the critical differential diagnoses (cervicogenic headache, migraine, trigeminal neuralgia, TON), primary/secondary classification and the limits of the diagnostic criteria.
The diagnosis rests on rigorous application of the ICHD-3 13.4 criteria, completed by a standardised physical examination and, ideally, confirmed by an anaesthetic block of the nerve concerned.¹ Imaging is not routine, but becomes essential as soon as a red flag is present or the response to well-conducted treatment is insufficient.²

Which questions should you ask to understand the patient and their history?

Structured questioning explores six key dimensions:
  • ⚡ Quality of the pain : paroxysmal in character (“a stab”, “an electric shock”, “a burn”), brief attacks lasting seconds to minutes, sometimes in salvoes. According to Melchior 2025, a shooting character is reported by 59 % of patients.³
  • Location : pain beginning in the suboccipital region and radiating towards the vertex, sometimes to the forehead, the orbit or the ear (trigeminocervical convergence). Unilateral in 81 % of cases.³
  • Triggers : neck movements (rotation, extension), pressure on the occiput (chair back, pillow), direct palpation along the course of the nerve, brushing the hair (allodynia).
  • Associated symptoms : dysaesthesia (abnormal sensations, tingling, burning) and scalp allodynia are close to pathognomonic. Mild visual discomfort (photophobia) is possible, but without the nausea typical of migraine.
  • Relevant past history : whiplash, posterior cervical surgery, head injury, recent shingles in the territory, a history of cancer, recent vaccination (cases reported after COVID-19 vaccination, but the evidence is weak).⁴
  • Yellow flags and contextual factors : kinesiophobia, catastrophising (Pain Catastrophizing Scale), sleep disturbance, level of occupational activity, workstation ergonomics.

Which clinical tests should you perform, and which other conditions should you rule out?

Standardised physical examination

  • Posture : looking for a forward head posture and a straightened or kyphotic upper cervical spine.
  • Cervical mobility : active and passive ranges, particularly C1-C2 rotation (the flexion-rotation test, the reference in cervicogenic headache, Hall 2010; not specific to ON).
  • The key diagnostic palpation : firm, sustained pressure at the emergence point of the GON, about 2-3 cm lateral and inferior to the external occipital protuberance, at the point where it pierces the trapezius aponeurosis.⁵ A reproduction of the typical pain is the most telling clinical finding.
  • Tinel's sign : gentle percussion along the course of the nerve, triggering an electric-shock sensation radiating towards the vertex.
  • Allodynia testing : light stroking of the scalp in the occipital territory, compared with the contralateral side.
  • Neurological assessment : sensation, motor function, reflexes. Any abnormality should prompt a rethink of the diagnosis and lead to imaging.

The greater occipital nerve block: the diagnostic gold standard

Under ICHD-3, criterion C for the neuralgias (including 13.4) requires the pain to be temporarily relieved by an anaesthetic block of the nerve concerned.¹ In practice the procedure means injecting a local anaesthetic (lidocaine 1-2 %, sometimes with a corticosteroid) at the emergence point of the nerve. The block can be performed using anatomical landmarks or guided by ultrasound, a technique increasingly used to improve accuracy and safety (Gürsoy & Tuna 2024, comparative RCT).⁶ The GON block also has a documented therapeutic value : Shauly 2019 (SR/MA, PMID 31568309)⁷ showed its efficacy in migraine headaches with occipital tenderness, and Cohen 2015 (RCT, PMID 26447705) compared block plus corticosteroid with pulsed radiofrequency in occipital neuralgia, with favourable results for both interventions.⁸ ⚠️ Limits of the block : a positive response may result from the anaesthetic diffusing to neighbouring pain-generating structures (C2-C3 facet joints, suboccipital muscles), producing false positives. Standardisation of the volume injected, the puncture point and the duration of post-block assessment remains imperfect, a limit acknowledged in the literature.⁹

Differential diagnosis

ConditionDistinguishing featuresLevel of evidence for the differential
Cervicogenic headache (ICHD-3 11.2.1)Unilateral pain referred from the upper cervical spine; reproduced by neck movement or facet palpation; the C1-C2 flexion-rotation test is relevant; an anaesthetic block of the facets or of the TON relieves it. Often confused with ON.High (Bogduk 2009, Lancet Neurol)¹⁰
Migraine (ICHD-3 1)Throbbing pain, lasting 4-72 h untreated, nausea or vomiting, photophobia and phonophobia, worse with activity. Allodynia is possible but without stabbing paroxysms.High (ICHD-3)¹
Tension-type headache (ICHD-3 2)Bilateral, vice-like pain, not paroxysmal, not worsened by activity.Moderate
Trigeminal neuralgia (ICHD-3 13.1)V territory (face), electric paroxysms, perioral trigger zones.Moderate
Third occipital nerve (TON) involvementUnilateral upper cervical pain, reproduced by C2-C3 movement; a TON block relieves it specifically.Moderate (Bogduk)¹⁰
Chronic post-traumatic headacheA clear history of head injury; a highly variable clinical picture; it can coexist with ON.Low (nosological overlap)

Should patients with occipital neuralgia be classified, and what are the benefits?

Yes. The distinction between primary (idiopathic) and secondary shapes the direction of treatment:
  • The primary form : management targeted on pain control, cervical rehabilitation (physiotherapy, exercise) and, depending on the course, blocks or pulsed radiofrequency.
  • The secondary form : treatment of the cause in parallel (muscular decompression, tumour removal, treatment of shingles, treatment of facet osteoarthritis, and so on). Imaging is essential.
A complementary topographical classification (GON, LON, TON) guides the anatomical targeting of blocks and, where relevant, of surgery. The literature remains poor in validated classifications specific to ON, unlike DC/TMD in temporomandibular disorders; that is a gap the coming decade will have to fill.²,³

Critique and controversy around the diagnosis

🧐 Several major limits still burden the diagnosis of occipital neuralgia in everyday practice:
  1. Variability of the clinical presentations and overlap with cervicogenic headache and migraine. The Melchior 2025 meta-analysis stresses the heterogeneity of the cohorts included, some of which do not follow ICHD-3 strictly.²,³
  2. False positives from the anaesthetic block through diffusion to neighbouring pain-generating structures (see Bogduk 2009).⁹,¹⁰
  3. The absence of a non-invasive clinical test with high sensitivity and specificity; palpation remains subjective.
  4. Frequent confusion with cervicogenic headache in the French-language literature, with variable terminology and therapeutic consequences that are not always appropriate.¹⁰

Key points

  • 📌 The ICHD-3 13.4 diagnosis : paroxysmal pain in the territory + dysaesthesia/allodynia + tenderness on palpation + relief from a block.
  • 📌 The key examination : palpation at the emergence point of the GON (2-3 cm lateral and inferior to the external occipital protuberance) reproducing the typical pain; Tinel's sign may be present.
  • 📌 The anaesthetic block is the diagnostic gold standard (and the start of treatment), ideally ultrasound-guided.
  • 📌 Differential diagnosis is mandatory : cervicogenic headache above all, migraine, tension-type headache, trigeminal neuralgia, TON involvement.
  • 📌 Primary/secondary classification is essential; a secondary cause calls for treating the cause and usually for imaging.
Bibliography
  1. Headache Classification Committee of the International Headache Society (IHS). ICHD-3, 3rd edition. Cephalalgia. 2018;38(1):1-211. PMID 29368949.
  2. Djavaherian DM, Guthmiller KB. Occipital Neuralgia. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024. NBK538281.
  3. Melchior AG, Al-Khazali S, Christensen RH, Al-Khazali HM, Ashina H. Epidemiology and clinical features of occipital neuralgia: A systematic review and meta-analysis. Cephalalgia. 2025;45(2):3331024251317595. PMID 40017062.
  4. Dougherty C. Occipital neuralgia. Curr Pain Headache Rep. 2014;18(5):411. PMID 24737457.
  5. Janis JE, Hatef DA, Reece EM, et al. The anatomy of the greater occipital nerve: Part II. Compression point topography. Plast Reconstr Surg. 2010;126(5):1563-1572. PMID 20639804.
  6. Gürsoy S, Tuna AT. Comparison of two methods of greater occipital nerve block in chronic migraine: ultrasound-guided and landmark-based. BMC Neurol. 2024;24:294. doi:10.1186/s12883-024-03816-8.
  7. Shauly O, Gould DJ, Sahai-Srivastava S, Patel KM. Greater Occipital Nerve Block for the Treatment of Chronic Migraine Headaches: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2019;144(4):943-952. PMID 31568309.
  8. Cohen SP, Peterlin BL, Fulton L, et al. Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness. Pain. 2015;156(12):2585-2594. PMID 26447705.
  9. Cesmebasi A, Muhleman MA, Hulsberg P, et al. Occipital neuralgia: anatomic considerations. Clin Anat. 2015;28(1):101-108. PMID 25244129.
  10. Bogduk N, Govind J. Cervicogenic headache: an assessment of the evidence. Lancet Neurol. 2009;8(10):959-968. PMID 19747657.

Which treatment strategies are the most effective for occipital neuralgia?

In this chapter: the four-level treatment pyramid (physiotherapy/education → GON block → pulsed radiofrequency → surgery), the pooled evidence of Deuel 2024 and Hong 2024, the place of targeted exercise (Demont 2023), cervical manual therapy (Núñez-Cabaleiro 2022, Jull 2002), pharmacology and psychosocial factors (Ehde 2014).
The treatment strategy recommended by the recent references, notably the Deuel 2024 review (Curr Pain Headache Rep)¹ and the meta-analyses Hong 2024 (Can J Pain)² and Liu 2025 (J Craniofac Surg)³, rests on a stepped and multimodalapproach. The general rule is to start with the least invasive options, reserving interventional techniques for carefully selected refractory cases. 🪜

Where do you start? What is the recommended hierarchy of interventions?

The classic hierarchy has four levels: Stepped treatment algorithm for occipital neuralgia Stepped treatment algorithm After Deuel 2024 (PMID 38958920), Hong 2024 (PMID 38915302), Cohen 2015 (PMID 26447705) 1: conservative first line Therapeutic education • Physiotherapy (C0-C2 mobilisations, motor control) • Ergonomics • Sleep hygiene 2: anaesthetic GON block (± corticosteroid) Diagnostic gold standard with therapeutic value (Shauly 2019 SR/MA, Cohen 2015 RCT); ideally ultrasound-guided 3: pulsed radiofrequency of the GON Where blocks fail or symptoms recur early; efficacy documented at 6-10 months (Hong 2024 SR · n=608, Cohen 2015 RCT) 4: occipital nerve stimulation (ONS) / surgical decompression Refractory cases; ONS: Sweet 2015 Neurosurgery; decompression: Liu 2025 SR/MA J Craniofac Surg ⚠ Throughout the pathway: red flags → MRI Resistance to treatment, neurological deficit, a history of cancer, immunosuppression, fever, weight loss Level 1: conservative. The Deuel 2024 review (PMID 38958920), the first modern synthesis devoted to conservative management of occipital neuralgia supported by physical therapy , explicitly recommends physiotherapy as first line, combined with therapeutic education of the patient.¹ The mechanistic rationale is threefold: myofascial decompression of the conflict points, cervical motor control to reduce the stress on the nerve, and central desensitisation through supervised exercise. Level 2: GON block. A combined lidocaine plus corticosteroid block gives relief lasting from a few weeks to several months (Shauly 2019, Cohen 2015).⁴,⁵ It can be repeated, particularly to start or to potentiate the rehabilitation programme. Level 3: pulsed radiofrequency (PRF). The Hong 2024 SR/MA (Canadian Journal of Pain, 22 pooled studies, n=608 patients) confirms the efficacy of PRF in headache including occipital neuralgia, with relief typically lasting between 6 and 10 months.² Cohen 2015 (RCT, 81 patients) had already shown numerical superiority of PRF over steroid block alone at 6 weeks, without the benefit being maintained beyond that.⁵ Level 4: surgical interventions. Occipital nerve stimulation (ONS) and surgical decompression of the GON are reserved for failure of the earlier steps. The Liu 2025 meta-analysis (J Craniofac Surg) brings together the nerve decompression data, suggesting favourable response rates but with variable quality of evidence and limited follow-up.³

What is the place of exercise, and is there a superior approach?

Exercise is central to management, but the literature specific to occipital neuralgia remains limited. The recommendations rest largely on extrapolation from the data on cervicogenic headache, a neighbouring condition sharing upper cervical mechanisms. 💪 🎯 The reference cervical programme. The Demont 2023 meta-analysis (PM&R, PMID 35596553) of physiotherapy RCTs in cervicogenic headache concludes that manual therapy is beneficial in the short term and cervical exercise in the long term.⁶ The pivotal trial Jull 2002 (Spine, PMID 12221344, n=200) showed that a programme of specific exercises (deep flexor training through the craniocervical flexion test, CCFT, Jull 2008 PMID 18804003) and cervical manipulation significantly reduced headache frequency and intensity at 12 months.⁷,⁸ Recommended components (extrapolated from cervicogenic headache):
  • Deep neck flexor training (longus colli, longus capitis): a progressive CCFT protocol up to 10 seconds × 10 repetitions at 26-30 mmHg on biofeedback.⁸
  • Cervical extensor endurance : isometric and endurance exercise.
  • Scapular stabilisation : strengthening middle and lower trapezius, the rhomboids and serratus anterior.
  • Stretching / mobility : upper trapezius, levator scapulae, scalenes, suboccipitals.
  • Global motor control : postural integration, awareness of forward head posture.

Manual therapies, technologies: how effective are they really?

👐 Manual therapies. The Núñez-Cabaleiro 2022 meta-analysis (Headache, PMID 35294051), focused on manual therapy in cervicogenic headache, concludes that there is moderate short-term efficacy on pain and function.⁹ The techniques evaluated include C0-C2 joint mobilisations, manipulation of the cervicothoracic junction, SNAGs and treatment of the suboccipital soft tissues. The network meta-analysis Xu & Ling 2025 (Front Neurol) confirms that no technique is clearly superior to another, with a generally favourable safety profile.¹⁰ 💡 Adjunctive technologies. For occipital neuralgia specifically:
  • TENS, ultrasound, low-level laser : indirect evidence, low to moderate, usable as symptomatic adjuncts.
  • Pulsed radiofrequency (PRF) : a medical intervention (not physiotherapy), with robust evidence (Hong 2024).²
  • Botulinum toxin : l'update 2025 (Toxicon) rates the efficacy in occipital neuralgia as “indeterminate”, for want of double-blind controlled studies of sufficient quality.¹¹
  • Acupuncture / dry needling : the data are still insufficient specifically for ON.
ModalityLevel of evidence (GRADE)Recommendation
GON block ± steroid (Shauly 2019, Cohen 2015)Moderate to highRecommended (diagnostic + therapeutic)
Pulsed radiofrequency (Hong 2024 SR)Moderate (6-10 month follow-up)Recommended as second or third line
Specific cervical physiotherapy (Demont 2023, Jull 2002)Moderate (extrapolated from CGH)Recommended first line
Manual therapy (Núñez-Cabaleiro 2022)Moderate (short term)Recommended alongside exercise
TENS, ultrasound, LLLTLowPossible adjunct, not as monotherapy
Botulinum toxin (Toxicon 2025)Very low (indeterminate)No formal recommendation
ONS / surgical decompression (Liu 2025)Low to moderate (refractory cases)Reserved for multimodal failure

Beyond the physical: how do you educate the patient and address psychological factors?

Therapeutic pain education is a pillar of management. It aims to reframe pain as a modifiable neurobiological phenomenon (Su 2022, Treede 2008), to reduce fear of movement (kinesiophobia) and catastrophising, and to build self-efficacy.¹²,¹³ Validated strategies:
  • Explaining the mechanisms (central sensitisation, trigeminocervical convergence, distinguishing migraine / ON / CGH);
  • Identifying personal triggers (sustained posture, stress, lack of sleep);
  • Relaxation and stress-management techniques (paced breathing, mindfulness);
  • Sleep hygiene (Finan 2013, on the sleep-pain relationship, PMID 24290442);¹⁴
  • Cognitive behavioural therapy (CBT) where catastrophising, anxiety or depression coexist (Ehde 2014, Am Psychol, meta-analysis of CBT in chronic pain, PMID 24547801).¹⁵
“No block and no radiofrequency replaces solid therapeutic education and a personalised exercise programme. The interventional procedure opens a window; it is for the patient and the physiotherapist to turn it into lasting recovery.”

Critique and controversy around treatment

🧐 The therapeutic field suffers from several limits:
  1. Few RCTs devoted specifically to occipital neuralgia ; most of the literature is extrapolated from cervicogenic headache or from migraine with occipital tenderness.¹,⁶
  2. Heterogeneous protocols (volumes injected, frequency of blocks, duration of PRF follow-up), which limits comparison.
  3. A moderate level of evidence at best for most interventions (Deuel 2024 says so explicitly).¹
  4. No standardised consensus on the threshold for moving from conservative to invasive treatment (how many blocks? after how many months?).
  5. A non-negligible risk of iatrogenic harm from repeated interventions (systemic corticosteroids, ONS, surgery).

Key points

  • ✅ A stepped algorithm : physiotherapy/education → GON block → pulsed radiofrequency → surgery.
  • 💉 The GON block is both diagnostic and therapeutic (Shauly 2019, Cohen 2015), ideally ultrasound-guided.
  • 💪 Specific cervical physiotherapy : deep flexor training (CCFT), C0-C2 manual therapy, counter-extension exercise.
  • 🧠 Pulsed radiofrequency is effective for 6-10 months (Hong 2024 SR/MA).
  • 🗣️ Therapeutic education + CBT are non-negotiable where the condition becomes chronic.
Bibliography
  1. Deuel D, Sandgren A, Nelson EO, Cropes M, Deacon A, Houdek T, Abd-Elsayed A. Conservative Management of Occipital Neuralgia Supported by Physical Therapy: A Review of Available Research and Mechanistic Rationale to Guide Treatment. Curr Pain Headache Rep. 2024;28(12):1321-1331. PMID 38958920.
  2. Hong AS, Hong J, Tieppo Francio V, Chang Chien GC, Sayed D, et al. Pulsed Radiofrequency Neuromodulation of the Greater Occipital Nerve for the Treatment of Headache Disorders in Adults: A Systematic Review. Can J Pain. 2024;8(1):2355571. PMID 38915302.
  3. Liu CY, Hsu YC, Lai CY, Wei FC. Nerve Decompression in Occipital Neuralgia: A Systematic Review and Meta-analysis. J Craniofac Surg. 2025 (Epub ahead of print). PMID 40367499.
  4. Shauly O, Gould DJ, Sahai-Srivastava S, Patel KM. Greater Occipital Nerve Block for the Treatment of Chronic Migraine Headaches: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2019;144(4):943-952. PMID 31568309.
  5. Cohen SP, Peterlin BL, Fulton L, et al. Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness. Pain. 2015;156(12):2585-2594. PMID 26447705.
  6. Demont A, Lafrance S, Gaska C, et al. Efficacy of physiotherapy interventions for the management of adults with cervicogenic headache: A systematic review and meta-analyses. PM&R. 2023;15(5):613-628. PMID 35596553.
  7. Jull G, Trott P, Potter H, et al. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine. 2002;27(17):1835-1843. PMID 12221344.
  8. Jull GA, O'Leary SP, Falla DL. Clinical assessment of the deep cervical flexor muscles: the craniocervical flexion test. J Manipulative Physiol Ther. 2008;31(7):525-533. PMID 18804003.
  9. Núñez-Cabaleiro P, Leirós-Rodríguez R. Effectiveness of manual therapy in the treatment of cervicogenic headache: A systematic review. Headache. 2022;62(3):271-283. PMID 35294051.
  10. Xu Y, Ling Y. Comparative safety and efficacy of manual therapy interventions for cervicogenic headache: a systematic review and network meta-analysis. Front Neurol. 2025;16:1566764. PMC 12123087.
  11. Update on botulinum toxin for occipital neuralgia. Toxicon. 2025. doi:10.1016/j.toxicon.2025.01.011.
  12. Su M, Yu S. Central Sensitization in Migraine: A Narrative Review. J Pain Res. 2022;15:2673-2682. PMC 9464439.
  13. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system. Neurology. 2008;70(18):1630-1635. PMID 18003941.
  14. Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14(12):1539-1552. PMID 24290442.
  15. Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153-166. PMID 24547801.

How do you secure lasting recovery and prevent recurrence of occipital neuralgia?

In this chapter: making the patient autonomous (Deuel 2024), ergonomic correction of forward head posture, a structured home programme (deep flexors, scapular muscles, stretching), sleep hygiene (Finan 2013), and a graded return to activity on functional criteria.
Long-term management goes beyond simply controlling the attacks. It aims to restore function, to prevent recurrence and to turn the patient into the principal agent of their own musculoskeletal health.¹ The evidence on how durable the results are remains limited, as most studies have less than 12 months of follow-up, but the rehabilitation principles for cervicogenic headache offer a robust framework to extrapolate from. 🧘

How do you make the patient an active participant in their recovery through self-management?

1. Pain education. The Deuel 2024 review stresses that pain neuroscience education is a prerequisite for any effective rehabilitation in occipital neuralgia.¹ It covers explaining central sensitisation, distinguishing neuralgia from migraine and cervicogenic headache, and dismantling limiting beliefs (“I must protect my neck”, “the more it hurts, the more damage I am doing”). 2. Ergonomics and posture. Forward head posture increases the mechanical stress on the upper cervical segments and the cervicothoracic junction. The classic recommendations:
  • Screen at eye height, at arm's length;
  • Regular breaks (20-20-20: every 20 minutes, for 20 seconds, look 20 feet away, about 6 m);
  • Less cumulative time in cervical flexion over a smartphone (“text neck”);
  • A pillow that allows neutral cervical alignment.
3. Home exercise programme. Structured on the principles of upper cervical physiotherapy (Jull 2002, Demont 2023):²,³
  • Deep flexor activation (head nodding against biofeedback or in lying);
  • Cervical extensor endurance (prone neck holds);
  • Scapular strengthening (Y/T/W, rowing);
  • Gentle stretching (upper trapezius, levator scapulae, suboccipitals), avoiding aggressive stretching while symptoms are active;
  • Upper thoracic mobility (cat-camel, extensions over a foam roller).
4. Myofascial self-release. Using a massage ball or a hook on the suboccipital muscles can give symptomatic relief in some patients. The specific evidence remains weak, but its safety and simplicity justify including it. 5. Sleep hygiene and stress management. Finan 2013 (J Pain) firmly established the two-way link between sleep and pain.⁴ Recommend:
  • Regular hours, a cool, dark environment;
  • Less screen time in the evening;
  • Relaxation techniques (paced breathing, body scan, mindfulness);
  • Regular physical activity (but not late in the evening);
  • Limiting stimulants (no caffeine after 2 pm).

When and how should a safe return to activity and to sport be planned?

🏃 The return to activity should be guided by functional criteria, not by a fixed calendar; there is no published standard specific to occipital neuralgia. Suggested progression criteria:
  1. Pain at rest < 3/10 on the VAS;
  2. Pain-free functional cervical ranges (rotation, flexion-extension);
  3. No symptoms during activities of daily living for 1-2 weeks.
A four-phase progression:
  • Phase 1 : low-impact aerobic activity (walking, upright cycling); no cervical stress.
  • Phase 2 : sport-specific movements at moderate intensity and without impact (light jogging, swimming with a board to limit cervical extension).
  • Phase 3 : progressively increasing complexity and intensity; introduction of specific strengthening. The non-aggravation rule: any significant increase in pain the following day → back to the previous phase.
  • Phase 4 : full return, without restriction, once every sport-specific movement is tolerated at full intensity.
Sports carrying particular risk (combat sports, contact sports, gymnastics, horse riding, rugby) warrant specific attention to cervical motor control before resuming.

Critique and controversy

🧐 The scientific literature has several limits:
  1. Considerable heterogeneity of rehabilitation protocols, most of them extrapolated from cervicogenic headache or from common neck pain.¹,³
  2. A lack of longitudinal studies specific to preventing recurrence in occipital neuralgia.
  3. No consensus on the criteria for returning to sport or to high-risk occupational activity.
  4. Under-assessment of psychosocial factors in the classic treatment studies, a point Deuel 2024 emphasises at length.¹

Key points

  • Autonomy comes through pain education, l'ergonomics and a home exercise programme.
  • A cervical programme built on the CCFT (Jull 2008) plus extensor endurance, scapular work and stretching.
  • Sleep hygiene + stress management modulate the sensitivity of the nervous system (Finan 2013).
  • Return to activity on functional criteria, not on a fixed delay.
  • ⚠ Longitudinal data and return-to-sport criteria for ON specifically are a major gap in the literature.
Bibliography
  1. Deuel D, Sandgren A, Nelson EO, et al. Conservative Management of Occipital Neuralgia Supported by Physical Therapy. Curr Pain Headache Rep. 2024;28(12):1321-1331. PMID 38958920.
  2. Jull G, Trott P, Potter H, et al. A randomized controlled trial of exercise and manipulative therapy for cervicogenic headache. Spine. 2002;27(17):1835-1843. PMID 12221344.
  3. Demont A, Lafrance S, Gaska C, et al. Efficacy of physiotherapy interventions for the management of adults with cervicogenic headache: SR and meta-analyses. PM&R. 2023;15(5):613-628. PMID 35596553.
  4. Finan PH, Goodin BR, Smith MT. The association of sleep and pain: an update and a path forward. J Pain. 2013;14(12):1539-1552. PMID 24290442.
  5. Jull GA, O'Leary SP, Falla DL. Clinical assessment of the deep cervical flexor muscles: the craniocervical flexion test. J Manipulative Physiol Ther. 2008;31(7):525-533. PMID 18804003.
  6. Núñez-Cabaleiro P, Leirós-Rodríguez R. Effectiveness of manual therapy in cervicogenic headache: SR. Headache. 2022;62(3):271-283. PMID 35294051.
  7. Page P. Cervicogenic headaches: an evidence-led approach to clinical management. Int J Sports Phys Ther. 2011;6(3):254-266. PMC 3201065.

What do real clinical cases teach us about occipital neuralgia?

In this chapter: clinical cases published on PubMed/PMC illustrating the range of causes (vascular compression, Choi 2017 PMC5346380; schwannoma, Krishnan 2015 PMID 26752925; C2 cavernoma PMC5898127; occipital condyle metastasis PMC9985513), mimicry of migraine, and the GRADE/CEBM evidence pyramid applied to case reports.
Studying genuinely published clinical cases, rather than invented illustrations, sheds light on the range of presentations and the diagnostic traps. The level of evidence of a case report (CEBM level 5) nonetheless demands caution: a case illustrates, it never proves efficacy, a fundamental point restated by Nissen & Wynn (BMC Res Notes 2014).¹ 🧐

Analysis of a “classic” case: from assessment to conservative resolution.

The literature offers few rigorously published physiotherapy case reports on isolated occipital neuralgia. The Deuel 2024 review (Curr Pain Headache Rep), the first mechanistic synthesis devoted to physiotherapy management of ON, identifies no specific RCT and rests on extrapolation from cervicogenic headache data.² The typical features of a successful conservative pathway (drawn together from Deuel 2024 and the Jull 2002 / Demont 2023 protocols):
  • Phase 1 (weeks 1-2) : pain education, identifying triggers, ergonomics, gentle isometric neck exercise;
  • Phase 2 (weeks 3-6) : manual therapy (C0-C2 mobilisations, suboccipital soft tissue), progression of the CCFT, scapular integration;
  • Phase 3 (weeks 7-12) : full strengthening, global motor control, return to activity;
  • Phase 4 (beyond) : autonomous maintenance, telephone follow-up or a consultation every 3-6 months to adjust prevention.
Where a GON block has been performed early in the pathway (both diagnostic and therapeutic), it can open the effective rehabilitation window by reducing pain significantly for several weeks.³,⁴

The diagnostic challenge: when occipital neuralgia mimics another condition.

🎯 Published case 1: vascular compression mimicking hemifacial migraine. Choi et al. (Case Rep Neurol Med 2017, PMC5346380) report a case of hemifacial pain with referred hemihypoaesthesia, initially attributed to migraine and finally diagnosed as occipital neuralgia secondary to pathological vascular contact between the occipital artery and the GON.⁵ Surgical neurovascular decompression resolved the symptoms. This case illustrates trigeminocervical convergence and the risk of misattributing the diagnosis. 🎯 Published case 2: occipital neuralgia after COVID-19 vaccination. Several open-access case reports (2022-2023) have described series of patients developing occipital neuralgia in the days after a second dose of an mRNA vaccine.⁶ The proposed mechanism is inflammatory or autoimmune, with no formal proof of causation. The evidence remains low level (case series, reporting bias), but the signal is worth documenting for pharmacovigilance. 🎯 Published case 3: an atypical presentation with maxillary radiation. Anatomical variations in the course of the GON (Cesmebasi 2015) explain why some patients have radiation into distant territories (maxilla, external ear), which can wrongly point towards trigeminal neuralgia or an ENT condition.⁷

A complex case: serious secondary causes.

🧬 Published case: schwannoma of the C2 root. Krishnan et al. (J Neurosci Rural Pract 2015, PMID 26752925) report a benign schwannoma of the C2 root in a patient with refractory occipital neuralgia.⁸ The anaesthetic blocks gave only fleeting relief, which prompted the cervical MRI that revealed the mass. Surgical resection brought complete resolution. This case is the paradigmatic illustration of the “resistance to well-conducted treatment” red flag. 🧬 Published case: C2 cavernoma. An intramedullary vascular malformation at C2 (PMC5898127) was found in a patient with chronic refractory ON, underlining that MRI must include the upper cord and the craniocervical junction.⁹ 🧬 Published case: Chiari I malformation. The association between ON and Chiari I is documented (PMC5788399); management requires a dedicated neurosurgical approach.¹⁰ 🧬 Published case: occipital condyle metastasis. One case (PMC9985513) shows a bone metastasis revealed by an occipital condyle syndrome mimicking ON, in a patient with a history of cancer.¹¹ It confirms the importance of the “history of cancer” red flag. 🧬 Published case: the paediatric population. Ehresman et al. (J Neurosurg Pediatr 2023, PMID 37548543) report a series of paediatric ON cases requiring surgical management, illustrating that a secondary cause should be sought more systematically in children and young adults.¹²

Critique and controversy

🧐 Published clinical cases have inherent limits:
  1. Publication bias : spectacular cases (exceptional treatment successes, highly atypical presentations) are over-represented.¹
  2. A low level of evidence : CEBM 5 / GRADE very low. A case illustrates, it never proves.
  3. The absence of longitudinal cohorts on occipital neuralgia specifically; the Melchior 2025 meta-analysis stresses this gap.¹³
  4. Heterogeneous diagnostic criteria between the published cases (some do not apply ICHD-3, others have no confirmatory anaesthetic block).

Key points

  • The clinical cases show the range of causes : compressive (muscular, vascular), tumour (schwannoma), malformation (Chiari), metastatic, post-traumatic.
  • The Resistance to well-conducted conservative treatment is the major red flag calling for MRI.
  • Occipital neuralgia is a great imitator (migraine, cervicogenic headache, trigeminal neuralgia) → rigorous differential diagnosis.
  • In children and young adults: look more systematically for a secondary cause (Ehresman 2023).
  • ⚠ The level of evidence of a case report is 5 (the weakest): follow the meta-analyses for treatment decisions.
Bibliography
  1. Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014;7:264. PMID 24758689.
  2. Deuel D, Sandgren A, Nelson EO, et al. Conservative Management of Occipital Neuralgia Supported by Physical Therapy. Curr Pain Headache Rep. 2024;28(12):1321-1331. PMID 38958920.
  3. Shauly O, Gould DJ, Sahai-Srivastava S, Patel KM. Greater Occipital Nerve Block for the Treatment of Chronic Migraine Headaches: SR/MA. Plast Reconstr Surg. 2019;144(4):943-952. PMID 31568309.
  4. Cohen SP, Peterlin BL, Fulton L, et al. RCT comparing pulsed radiofrequency to steroid injections for occipital neuralgia. Pain. 2015;156(12):2585-2594. PMID 26447705.
  5. Choi JG, Kang YJ, Kim BC, Lee CG, Choi SK. Hemifacial Pain and Hemisensory Disturbance Referred from Occipital Neuralgia. Case Rep Neurol Med. 2017;2017:3827230. PMC 5346380.
  6. Occipital Neuralgia after COVID-19 Vaccination: Case report (open access). 2023.
  7. Cesmebasi A, Muhleman MA, Hulsberg P, et al. Occipital neuralgia: anatomic considerations. Clin Anat. 2015;28(1):101-108. PMID 25244129.
  8. Krishnan A, Kartikueyan R, Chowdhury SR, Das S. Schwannoma of the greater occipital nerve. J Neurosci Rural Pract. 2015;6(4):634-636. PMID 26752925.
  9. Occipital neuralgia from C2 cavernous malformation. Surg Neurol Int. 2018. PMC 5898127.
  10. Occipital Neuralgia in Chiari I Malformation. Acta Neurochir Suppl. 2018. PMC 5788399.
  11. Occipital condyle syndrome, metastatic breast cancer (case report PMC). 2023. PMC 9985513.
  12. Ehresman J, Polly DW, Hsu W, Witham TF, Lubelski D. Surgical management of pediatric occipital neuralgia: a single-center experience. J Neurosurg Pediatr. 2023;32(4):514-519. PMID 37548543.
  13. Melchior AG, Al-Khazali S, Christensen RH, et al. Epidemiology and clinical features of occipital neuralgia: SR/MA. Cephalalgia. 2025;45(2):3331024251317595. PMID 40017062.

How do you apply these recommendations concretely in your practice?

In this chapter: the specific red flags (Finucane 2020), a critique of red flags (Verhagen 2017, Han 2023 Cochrane), yellow flags, interprofessional collaboration, validated PROMs (NDI, HIT-6, MIDAS, PCS, TSK-11), the barriers to and facilitators of EBP (Cumpston 2019), and clinical reasoning beyond the checklist.
Applying evidence-based recommendations is the bridge between the science and the patient's outcome. It presupposes a threefold skill: identifying the situations that exceed your scope (medical referral), measuring the effect of the interventions (PROMs), and overcoming the barriers to EBP in everyday practice. 🤔

When and to which other health professionals should you refer?

Red flags call for prompt medical referral. The IFOMPT framework of Finucane et al. (JOSPT 2020, PMID 32438853) remains the French and international reference for spinal red flags.¹ Verhagen et al. (Pain 2017, PMID 28708761) showed, however, that most red flags taken in isolation have a low positive predictive value, hence the need to read them as a cluster of findings.² The Cochrane review Han 2023 (CD014461) confirms this probabilistic logic for vertebral fracture in low back pain: combining several flags significantly raises the post-test probability, whereas the absence of red flags reasonably rules out serious disease.³ Specifically for occipital neuralgia, the situations calling for medical referral (GP, neurologist, pain specialist or the emergency department depending on context) are:
  • A thunderclap headache or one of sudden onset → subarachnoid haemorrhage, arterial dissection;
  • A focal neurological deficit (weakness, ataxia, visual disturbance);
  • A known history of cancer or unexplained weight loss;
  • Fever + neck stiffness → infection;
  • Resistance to well-conducted conservative treatment (4-6 weeks) → cervical and brain MRI;
  • Recurrence after posterior cervical surgery → suspected postoperative fibrosis or iatrogenic injury.
The yellow flags (kinesiophobia, catastrophising, anxiety, depression, poor social support) are major predictors of the condition becoming chronic and call for collaboration with a psychologist, a pain physician or a multidisciplinary team. 🩺 Interprofessional collaboration. The complexity of occipital neuralgia justifies potentially involving:
  • A GP or neurologist (differential diagnosis, prescribing, imaging);
  • A pain specialist (nerve blocks, pulsed radiofrequency);
  • A neurosurgeon (surgical cases: decompression, ONS);
  • A psychologist or psychiatrist (CBT, managing comorbidity);
  • An ergonomist or occupational physician (workstation adaptation).

How do you measure outcomes and overcome barriers to implementation?

📈 Measuring outcomes with validated PROMs. Standardised follow-up should combine:
  • VAS / NRS for pain (at rest, on exertion, during an attack);
  • The Neck Disability Index (NDI) for cervical functional impact;
  • HIT-6 or MIDAS for headache-specific impact;
  • The Pain Catastrophizing Scale (PCS) and the Tampa Scale of Kinesiophobia (TSK-11) for the psychological factors;
  • Physical performance measures: cervical ranges, CCFT score (mmHg of pressure held × seconds).
🚧 Overcoming the barriers to EBP. Systematic reviews invariably identify three main obstacles to implementation: lack of time, lack of research skills, lack of organisational support. Effective strategies (beyond simply circulating guidelines passively):
  • Targeted continuing education on critical appraisal of papers and applied statistics;
  • Using evidence syntheses (Cochrane Reviews, BMJ Best Practice, the Physio Learning syntheses) to save time;⁴
  • Audit and feedback on your own practice (rate of PROM use, adherence to the recommendations);
  • Clinical leadership and mentoring by “EBP champions”;
  • Technological integration (patient record software with PROMs built in).
“The best science in the world changes nothing if it stays in the papers. Implementation is the operational ethics of evidence-based practice: what we do, not only what we know.”

Critique and controversy: beyond the checklist

🧐 Three critical tensions run through the application of EBP in practice:
  1. Reductionism. Red flags can lead to an anxiety-driven “hunt for pathology” that neglects the biopsychosocial context. Conversely, a PROM score captures only part of the human experience. Expert competence uses these tools without being confined to them.
  2. The knowing-doing gap. The barriers identified (time, skills, support) have been strikingly stable for 20 years. That suggests the problem is not purely individual: the health systems (reimbursement models, administrative burden, initial training) need rethinking to favour EBP.
  3. Standardisation vs personalisation. Core Outcome Sets and standardised care pathways are essential for research and quality, but they can pull against a patient-centred approach. Clinical artistry lies in reconciling the two.
Finally, the emergence of artificial intelligence in decision support raises both opportunities (real-time access to the evidence, suggested differential diagnoses) and risks (dehumanisation, deskilling, accountability). Balancing technological augmentation against the autonomy of clinical judgement will be the challenge of the coming decade.

Key points

  • The red flags should be read as a cluster (Verhagen 2017, Han 2023); the Finucane 2020 framework remains the reference.
  • The yellow flags (kinesiophobia, catastrophising) call for collaboration with a psychologist.
  • The interprofessional collaboration (doctor, neurologist, pain specialist, psychologist, neurosurgeon) is central in complex cases.
  • Measuring outcomes with validated PROMs (VAS, NDI, HIT-6, MIDAS, PCS, TSK-11) is non-negotiable.
  • Overcoming the barriers to EBP requires a multifaceted approach (training, evidence syntheses, audit, leadership).
  • Beyond the checklist: holistic clinical reasoning, shared decision-making, and attention to the systems that hold EBP back.
Bibliography
  1. Finucane LM, Downie A, Mercer C, Greenhalgh SM, Boissonnault WG, Pool-Goudzwaard AL, et al. International Framework for Red Flags for Potential Serious Spinal Pathologies. J Orthop Sports Phys Ther. 2020;50(7):350-372. PMID 32438853.
  2. Verhagen AP, Downie A, Maher CG, Koes BW. Most red flags for malignancy in low back pain guidelines lack empirical support: a systematic review. Pain. 2017;158(10):1860-1868. PMID 28708761.
  3. Han CS, Hancock MJ, Downie A, et al. Red flags to screen for vertebral fracture in people presenting with low back pain. Cochrane Database Syst Rev. 2023;Issue 8:CD014461. doi:10.1002/14651858.CD014461.pub2.
  4. Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev. 2019;10:ED000142. PMID 31643080.
  5. Deuel D, Sandgren A, Nelson EO, et al. Conservative Management of Occipital Neuralgia Supported by Physical Therapy. Curr Pain Headache Rep. 2024;28(12):1321-1331. PMID 38958920.
  6. Núñez-Cabaleiro P, Leirós-Rodríguez R. Effectiveness of manual therapy in cervicogenic headache: SR. Headache. 2022;62(3):271-283. PMID 35294051.

And after this article?

This article is part of a collection of evidence-based clinical syntheses. A question, a comment, a correction to suggest? Contact us directly through the WhatsApp button at the bottom right of the screen.

↑ Back to contents PubMed sources

Physio Learning: evidence-based clinical syntheses

This article has undergone rigorous bibliographic checking: every reference cited is linked to a verified PubMed PMID or CrossRef DOI. The figures and claims are sourced. The clinical cases cited come from the published literature.

Last revisedMay 2026 MethodA synthesis of meta-analyses + international consensus statements Level of evidenceMixed (from level 1a meta-analyses to level 5 case reports, ranked within the article) Conflicts of interestNone declared A question, or spotted an error?WhatsApp button at the bottom right of the screen 💬
⏱️Find out moreOccipital neuralgia: duration, course and danger →

Further reading in the review

Behind this article

An author who explains, a reviewer who checks.

How we write and check our content

Anthony Baillon, physiotherapist and co-founder of Physio Learning
✍️ Author

Anthony Baillon

Physiotherapist · co-founder of Physio Learning

Marked for life by his first four-hour lecture without a single image, he took a master’s in instructional design so that it would never happen to anyone again. He hunts down publication bias and unreadable slides with the same intransigence.

PhysiotherapistInstructional designerCare design
Follow on LinkedIn
Robin Vervaeke, head of scientific content at Physio Learning✓ Verified

Robin Vervaeke

Head of scientific content

Physiotherapist specialising in neuro-musculoskeletal practice and holder of a master’s in public health. He checks the methodological rigour of every article: primary sources, levels of evidence, no exceptions.

Neuro-musculoskeletalMSc Public health
Follow on LinkedIn

Share